Baxter acquires Baxa
Baxa is known for developing pharmacy technology to improve the efficiency and safety of oral and IV dose preparation and delivery. Baxter Medical Products business president Robert Davis
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.